Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel J P, Agbalika F
Department of Immunology and Hematology, Laboratory of Virology, Hôpital Saint-Louis, Paris, France.
Blood. 2000 Sep 15;96(6):2069-73.
Multicentric Castleman disease (MCD) is a distinct type of lymphoproliferative disorder associated with inflammatory symptoms and interleukin-6 (IL-6) dysregulation. In the context of human immunodeficiency virus (HIV) infection, MCD is associated with human herpesvirus 8 (HHV8) infection. In a prospective study of 23 HIV-infected patients with MCD, clinical symptoms of MCD were present at 45 visits, whereas patients were in chemotherapy-induced clinical remission at 50 visits. Symptoms were associated with a high level of serum C reactive protein, high HHV8 viral load in peripheral blood mononuclear cells, and high plasma human IL-6 and IL-10 levels. Strong correlations between plasma IL-6 and plasma IL-10 with the HHV8 viral load suggest that both cytokines may be involved in the pathogenesis of this virus-associated lymphoproliferative disorder.
多中心Castleman病(MCD)是一种独特的淋巴增殖性疾病,与炎症症状和白细胞介素-6(IL-6)失调相关。在人类免疫缺陷病毒(HIV)感染的背景下,MCD与人类疱疹病毒8(HHV8)感染有关。在一项对23例HIV感染的MCD患者的前瞻性研究中,45次就诊时出现了MCD的临床症状,而50次就诊时患者处于化疗诱导的临床缓解期。症状与血清C反应蛋白水平升高、外周血单个核细胞中HHV8病毒载量高以及血浆人IL-6和IL-10水平高有关。血浆IL-6和血浆IL-10与HHV8病毒载量之间的强相关性表明,这两种细胞因子可能都参与了这种病毒相关淋巴增殖性疾病的发病机制。